Alkem Laboratories

Alkem Laboratories, headquartered in India and operating in Pharmaceutical Preparation Manufacturing, reported Scope 1 emissions of 33,018,000 kg CO2e and Scope 2 emissions of 76,079,000 kg CO2e for the year 2025. In 2024, the company's Scope 1 emissions were 19,249,000 kg CO2e, Scope 2 emissions were 82,319,000 kg CO2e, and Scope 3 emissions were 365,176,000 kg CO2e. For 2023, Alkem Laboratories disclosed Scope 1 emissions of 15,773,000 kg CO2e, Scope 2 emissions of 82,319,000 kg CO2e (both market-based and location-based), and Scope 3 emissions of 365,176,000 kg CO2e. In 2022, Scope 1 emissions were 15,773,000 kg CO2e, and Scope 2 emissions (market-based and location-based) were 78,502,000 kg CO2e. Looking back to 2021, the company's Scope 1 emissions were 20,621,000 kg CO2e, and Scope 2 emissions (market-based and location-based) were 94,284,000 kg CO2e.

Alkem Laboratories has established climate commitments, including a target to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42% by the financial year 2033, against a baseline of financial year 2023. Additionally, the company aims to reduce GHG emissions (Scope 1 & 2) by the financial year 2032-33, from a baseline of financial year 2022-23.